Order Article Reprints

Iancu DG, Cristescu L, Mares RG, Varga A, Tilea I. Reply to Pagnoni et al. Clarifying the Clinical Utility of NTAR/RGR for PAH and CTEPH. Comment on “Iancu et al. Evaluating NT-proBNP-to-Albumin (NTAR) and RDW-to-eGFR (RGR) Ratios as Biomarkers for Predicting Hospitalization Duration and Mortality in Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH). Diagnostics 2025, 15, 2126”. Diagnostics. 2026; 16(1):56. https://doi.org/10.3390/diagnostics16010056

Iancu, Dragos Gabriel, Liviu Cristescu, Razvan Gheorghita Mares, Andreea Varga, and Ioan Tilea. 2026. "Reply to Pagnoni et al. Clarifying the Clinical Utility of NTAR/RGR for PAH and CTEPH. Comment on “Iancu et al. Evaluating NT-proBNP-to-Albumin (NTAR) and RDW-to-eGFR (RGR) Ratios as Biomarkers for Predicting Hospitalization Duration and Mortality in Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH). Diagnostics 2025, 15, 2126”" Diagnostics 16, no. 1: 56. https://doi.org/10.3390/diagnostics16010056

Iancu, D. G., Cristescu, L., Mares, R. G., Varga, A., & Tilea, I. (2026). Reply to Pagnoni et al. Clarifying the Clinical Utility of NTAR/RGR for PAH and CTEPH. Comment on “Iancu et al. Evaluating NT-proBNP-to-Albumin (NTAR) and RDW-to-eGFR (RGR) Ratios as Biomarkers for Predicting Hospitalization Duration and Mortality in Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH). Diagnostics 2025, 15, 2126”. Diagnostics, 16(1), 56. https://doi.org/10.3390/diagnostics16010056